Baird Downgrades Merge Healthcare (MRGE) to Neutral

Dougherty & Co downgraded Merge Healthcare (NASDAQ: MRGE) from Buy to Sell. The change follows its merger agreement with IBM. Analyst Brooks O'Neil doesn't expect a competing bid.

For an analyst ratings summary and ratings history on Merge Healthcare... More

IBM (IBM) to Acquire Merge Healthcare (MRGE) in $1B Deal

August 6, 2015 9:20 AM EDT

IBM (NYSE: IBM) announced that Watson will gain the ability to "see" by bringing together Watson's advanced image analytics and cognitive capabilities with data and images obtained from Merge Healthcare Incorporated's (NASDAQ: MRGE) medical imaging management platform. IBM plans to acquire Merge, a leading provider of medical image handling and processing, interoperability and clinical systems designed to advance healthcare quality and efficiency, in an effort to unlock the value of medical images to help physicians make better patient care decisions.

Merge's technology platforms are... More

Baird Downgrades Merge Healthcare (MRGE) to Neutral

Baird Downgrades Merge Healthcare (MRGE) to Neutral

Topeka Capital Downgrades Merge Healthcare (MRGE) to Hold

Dougherty & Co Downgrades Merge Healthcare (MRGE) to Sell

IBM (IBM) to Acquire Merge Healthcare (MRGE) in $1B Deal

Free News Feed